NAD+: Guide to the Metabolism Coenzyme
The coenzyme consumed by sirtuins and DNA-repair systems: why its scale is hundreds of milligrams and not ten.
— Peptigene
The coenzyme consumed by sirtuins and DNA-repair systems: why its scale is hundreds of milligrams and not ten.
The copper tripeptide with five decades of research behind it: what the evidence says, why the blue colour matters and how to judge quality.
Four peptides in one vial: what each one contributes, when a blend makes sense and when it is better to work with the compounds separately.
The Russian heptapeptide derived from tuftsin: research lines, its unusual regulatory status and what to check when buying it.
Not a peptide, and its mechanism has nothing to do with incretins: what ERR receptors are and why its preclinical stage matters.
A high-purity peptide can be ruined at reconstitution: diluent differences, concentration maths and the most frequent errors.
The dual GIP/GLP-1 mechanism, the difference between research material and the pharmaceutical drug, and how to judge the quality of the compound.
Two receptors against three: mechanism, maturity of the evidence, regulatory status and which one fits each type of protocol.
What the GIP/GLP-1/glucagon triple agonist is, where its research stands, its legal status in Colombia and the criteria for judging a supplier.